6 Dec 2021
BD Selects “embecta” as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
Author: admintech | Filed under: Press ReleaseFRANKLIN LAKES, N.J., Dec. 6, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that “embecta” [pronounced em-BECK-tah] will be the name of the independent, publicly-traded company that will hold BD’s Diabetes…